Bing‐Ching Ho

1.6k citations
29 papers · 1.2k indexed · 1 hit paper · h-index 17

Impact in

    • Cancer Genomics and Diagnostics
    • MicroRNA in disease regulation
  • Oncology top 10%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies

Papers in

    • Cancer Genomics and Diagnostics 5
    • MicroRNA in disease regulation 4
    • RNA regulation and disease 5
    • RNA Research and Splicing 5

Bing‐Ching Ho

29 papers receiving 1.2k citations

Hit Papers

Pretreatment Epidermal Growth Factor Receptor ( EGFR ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer 2012 · 429 citations
4292012202620162021100200300400

Peers

Bing‐Ching Ho
Comparison fields: 5 of 100
  • Cancer Research 420
  • Oncology 352
  • Pulmonary and Respiratory Medicine 409
  • Molecular Biology 627
  • Immunology 160
Replace Hien Dang with:
Hien Dang United States
Thomas F. Baumert France
Ai‐Yu Gong United States
Xueyan Duan China
Ebrahim Faghihloo Iran
Payel Chatterjee United States
Yonghua Bao China
Qiang Hou China
Laurens Wachsmuth Germany
E. Uchida Japan
Bing‐Ching Ho relative to Hien Dang United States Hien Dang's profile →
Citations per field
00.5×3.6×
Hien Dang · 1×
Citations per year

Countries citing papers authored by Bing‐Ching Ho

Since Specialization
Citations

This map shows the geographic impact of Bing‐Ching Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing‐Ching Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing‐Ching Ho more than expected).

Fields of papers citing papers by Bing‐Ching Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing‐Ching Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing‐Ching Ho. The network helps show where Bing‐Ching Ho may publish in the future.

Co-authors

The 25 scholars most cited alongside Bing‐Ching Ho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bing‐Ching Ho Line = papers co-authored together Bing‐Ching Ho links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202111
2 20215
3 20205
4 201917
5 201915
6 201810
7 201726
8 201624
9 201620
10 201614
11 20162
12 201639
13 201575
14 201511
15 2014120
16 201345
17
Pretreatment Epidermal Growth Factor Receptor ( EGFR ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer
Hit paper breakdown →
2012429
18 2011128
19 200946
20 200936

About Bing‐Ching Ho

Bing‐Ching Ho is a scholar working on Cancer Research, Molecular Biology, Oncology, Cardiology and Cardiovascular Medicine and Molecular Medicine, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA regulation and disease (5 papers), Viral Infections and Immunology Research (5 papers), Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers), RNA Research and Splicing (5 papers), MicroRNA in disease regulation (4 papers), Lung Cancer Research Studies (3 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Cancer Research (420 citations), Oncology (352 citations), Pulmonary and Respiratory Medicine (409 citations), Molecular Biology (627 citations) and Immunology (160 citations). Bing‐Ching Ho has collaborated with scholars based in Taiwan, United States and Australia. Frequent co-authors include Sung‐Liang Yu, Pan‐Chyr Yang, Kang‐Yi Su, Gee‐Chen Chang, Min‐Liang Kuo, Ker-Chau Li, Jin‐Yuan Shih, James Chih‐Hsin Yang, Wing‐Kai Chan and Hsuan‐Yu Chen. Their work appears in journals such as Oncotarget, PLoS ONE, Journal of Cellular Biochemistry, Scientific Reports and Cellular Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026